Together Pharma Ltd (TGTR.TA)
ILA 421.9
(-1.29%)
ILA 421.9
(-1.29%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 91 Million ILS | 191.42% |
| 2022 | 31.22 Million ILS | 159.67% |
| 2021 | 12.02 Million ILS | 7.15% |
| 2020 | 11.22 Million ILS | 0.0% |
| 2019 | - ILS | 0.0% |
| 2018 | - ILS | 0.0% |
| 2017 | - ILS | 0.0% |
| 2016 | - ILS | -100.0% |
| 2015 | 12.11 Million ILS | 59.69% |
| 2014 | 7.58 Million ILS | 537.82% |
| 2013 | 1.18 Million ILS | 3085.54% |
| 2012 | 37.33 Thousand ILS | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 25.2 Million ILS | 10.81% |
| 2024 Q2 | 25.2 Million ILS | 0.0% |
| 2023 Q2 | 22.76 Million ILS | 0.0% |
| 2023 Q3 | 22.74 Million ILA | -0.07% |
| 2023 Q4 | 22.74 Million ILS | 0.0% |
| 2023 FY | 91 Million ILS | 191.42% |
| 2023 Q1 | 22.76 Million ILS | 112.88% |
| 2022 FY | 31.22 Million ILS | 159.67% |
| 2022 Q1 | 4.92 Million ILS | 183.88% |
| 2022 Q2 | 4.92 Million ILS | 0.0% |
| 2022 Q3 | 10.69 Million ILS | 117.2% |
| 2022 Q4 | 10.69 Million ILS | 0.0% |
| 2021 FY | 12.02 Million ILS | 7.15% |
| 2021 Q4 | 1.73 Million ILS | -54.45% |
| 2021 Q3 | 3.8 Million ILS | 35.96% |
| 2021 Q2 | 2.8 Million ILS | -13.58% |
| 2021 Q1 | 3.24 Million ILS | -18.16% |
| 2020 Q3 | 2.81 Million ILS | -4.61% |
| 2020 Q2 | 2.94 Million ILS | 109.3% |
| 2020 FY | 11.22 Million ILS | 0.0% |
| 2020 Q1 | 1.4 Million ILS | 0.0% |
| 2020 Q4 | 3.95 Million ILS | 40.74% |
| 2019 Q1 | 428 Thousand ILS | 0.0% |
| 2019 Q4 | - ILS | 0.0% |
| 2019 FY | - ILS | 0.0% |
| 2019 Q2 | 428 Thousand ILS | 0.0% |
| 2019 Q3 | - ILS | -100.0% |
| 2018 Q4 | - ILS | 0.0% |
| 2018 Q1 | - ILS | 0.0% |
| 2018 Q2 | - ILS | 0.0% |
| 2018 FY | - ILS | 0.0% |
| 2018 Q3 | - ILS | 0.0% |
| 2017 Q2 | - ILS | 0.0% |
| 2017 FY | - ILS | 0.0% |
| 2017 Q4 | - ILS | 0.0% |
| 2017 Q3 | - ILS | 0.0% |
| 2017 Q1 | - ILS | 0.0% |
| 2016 Q4 | - ILS | 0.0% |
| 2016 Q2 | - ILS | -100.0% |
| 2016 Q3 | - ILS | 0.0% |
| 2016 Q1 | 1.99 Million ILS | -47.89% |
| 2016 FY | - ILS | -100.0% |
| 2015 FY | 12.11 Million ILS | 59.69% |
| 2015 Q2 | 3.27 Million ILS | 36.1% |
| 2015 Q1 | 2.4 Million ILS | -24.58% |
| 2015 Q3 | 2.59 Million ILS | -20.88% |
| 2015 Q4 | 3.83 Million ILS | 47.93% |
| 2014 Q3 | 2.03 Million ILS | 2.93% |
| 2014 Q1 | - ILS | -100.0% |
| 2014 FY | 7.58 Million ILS | 537.82% |
| 2014 Q4 | 3.19 Million ILS | 56.95% |
| 2014 Q2 | 1.97 Million ILS | 0.0% |
| 2013 Q2 | 254.51 Thousand ILS | 598.01% |
| 2013 FY | 1.18 Million ILS | 3085.54% |
| 2013 Q3 | 398.49 Thousand ILS | 56.57% |
| 2013 Q4 | 520.14 Thousand ILS | 30.53% |
| 2013 Q1 | 36.46 Thousand ILS | -2.34% |
| 2012 Q4 | 37.33 Thousand ILS | 0.0% |
| 2012 FY | 37.33 Thousand ILS | 0.0% |
| 2012 Q3 | - ILS | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cannabotech LTD | 1.21 Million ILA | -7365.628% |